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The existence of a protracted course in crescentic glomerulonephritis.
We describe a spectrum of clinical and morphologic features which may
occur in idiopathic crescentic glomerulonephritis. Of note are patients
who pursue a more indolent course to renal failure in contrast to typical
rapidly progressive glomerulonephritis (RPGN). Patients following this
protracted course have an insidious presentation with hematuria and
renal insufficiency, and at the time of renal biopsy (usually after many
months of clinical illness) show less extensive involvement with cres-
cents, which are often in both cellular and fibrous stages. This form of
crescentic glomerulonephritis is further distinguished from RPGN by
frequent hypertension and the nephrotic syndrome, the absence of
oligo-anuria and progression to renal failure over many months or even
years.
Extracapillary proliferative (or crescentic) glomerulonephri-
tis has commonly been equated with fulminant renal failure.
Although it is agreed that patients with widespread circumfer-
ential cellular crescents do in fact follow the course of rapidly
progressive glomerulonephritis (RPGN), the rather indolent
progression to uremia of those with less extensive extracapil-
lary involvement and with mixed cellular and fibrous structures
has not been sufficiently recognized [1, 3—19]. It is the purpose
of the present work to describe the spectrum of clinical and
morphologic features which may occur in crescentic glomeru-
lonephritis in order to emphasize the existence of a protracted
course which occurs in some individuals. This form of crescen-
tic disease can be identified by its own highly distinctive
constellation of clinical features: the insidious appearance of
hematuria and renal insufficiency, a tendency to heavy protein-
uria, and an inexorable decline in renal function over months to
years.
Methods
In a review of pathologic material (renal biopsy and post
mortem) available for the period 1965 to 1979 at New York
University and Bellevue Hospitals, specimens were identified
in which extracapillary proliferation was the predominant
glomerular abnormality in sections containing at least eight
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glomeruli. A minimum percent crescents was not made a
requirement, but the number equalled or exceeded 50% on
initial or subsequent histologic examinations in 19 of the 26
patients who were considered eligible for the present study
according to the criteria which follow. The study was restricted
to patients with idiopathic crescentic glomerulonephritis, al-
though such individuals do not necessarily comprise a nosologic
entity. Those in whom clinical, laboratory and pathologic data
suggested the presence of an underlying systemic disease were
eliminated from consideration, since the extra—renal manifesta-
tions of their illness and the treatment employed often played a
major role in their course. Similarly, instances of post-infec-
tious glomerulonephritis, which is primarily an endocapillary
disease, were excluded even though crescents were present. In
order to record the natural history of this disorder, we also
eliminated patients in whom therapy with corticosteroids, im-
munosuppressives or anticoagulants appeared to induce a re-
mission. Seven patients are included who received such treat-
ment after the development of uremia and made no clinical
response, as are three other patients who were given a short
course of prednisone or anticoagulants early in their course yet
ultimately progressed to uremia. We cannot be certain that
apparently unsuccessful therapy may not have influenced the
rate of progression in these three. Utilizing these criteria, 26
patients remained eligible for this natural history study. A total
of 39 pathologic specimens were examined in these 26 patients.
The percent of glomeruli with crescents on initial renal biopsy,
expressed as the number of glomeruli with extracapillary pro-
liferation divided by the total number of glomeruli in the
sample, was 50% or more in 16 cases and ranged from 17 to 44%
in the other 10. Three of the latter showed greater than 50%
crescents on subsequent examination. Endocapillary hyper-
cellularity was absent in 14 cases and was present focally in the
remaining 12. Methods employed in the preparation and analy-
sis of pathologic specimens by light, electron and im-
munofluorescence microscopy have previously been described
[2]. Patients were hospitalized at New York University Medical
Center or Bellevue Hospital, where all laboratory studies were
performed. Onset of disease was taken as the time of appear-
ance or discovery of clinical manifestations, even though this
may not correspond to biologic onset. Follow—up for at least
one year or until death or dialysis was available in all.
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Fig. 1. Clinical course of Group I patients, rapidly progressive cres-
centic glomerulonephritis. Values for serum creatinine in mgldl are
shown within the bars. Symbols are: (u) initiation of dialysis;(t)death;
(Y) renal biopsy or post-mortem; () proteinuria; (•) nephrolic
syndrome.
Clinical features
Based on their clinical course, patients were categorized into
one of two groups: Group 1(10 patients) progressed rapidly to
advanced renal failure within four months of presentation.
Group 11(16 patients) followed an indolent course, 14 progress-
ing to renal failure over periods of one to 10 years.
Group I: Rapidly progressive renal failure
The 10 patients in Group! ranged in age from 20 to 72 years; five
were men (Fig. 1). Extra—renal clinical manifestations occurred in
six and included fever, sore throat and myalgia. Hypertension was
present at onset in two, appeared with the development of uremia
in one and was long—standing in two. All exhibited proteinuria and
hematuria (gross in 3). The nephrotic syndrome (proteinuria in
excess of 4 g!24 hrs, serum albumin less than 3 g/dl and edema)
was present in only one. Proteinuria in the remaining patients
ranged from 600 mg to 1.7 g/24 hours. Oliguria, (urine output less
than 500 ml124 hrs) occurred in six. All patients in Group I
progressed to irreversible uremia within four months of presenta-
tion (mean 38 days). Seven patients died one to 11 months after the
appearance of clinical manifestations.
Group II: Slowly progressive renal failure
The 16 patients in Group I!, 10 men and six women, ranged in
Fig. 2. Clinical course of Group I/patients, "not so rapidly progres-
sive" crescentic glomerulonephritis. Values for serum creatinine in
mg/dl are shown within the bars. (H) history of hematuria; other
symbols are the same as in Figure I.
age from 14 to 67 years (Fig. 2). In contrast to Group I, who
presented with rapidly progressive renal failure, patients in
Group II were often referred for nephrologic evaluation after
many months of illness manifested by either urinary abnormal-
ities, mild to moderate renal insufficiency or the nephrotic
syndrome. Extra—renal manifestations included arthralgia and
hemoptysis, each in one case. Hypertension was observed in 14
patients, four at presentation and 10 later in the course. All
exhibited proteinuria and hematuria (gross in 4). Unremitting
nephrotic syndrome existed at clinical presentation in six pa-
tients and developed later in two others.
Serum creatinine levels initially ranged from 0.5 to 6.5 mg/dl.
Oliguria was not a feature in any patient. Eleven progressed to
uremia over periods ranging from one to 9-1/2 years; five of
these subsequently succumbed. Of the remaining five patients,
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Table 1. Group I morphologic features
Crescents
Time from Total Circumferential Global Focal
clinical onset sclerosis endocapillary Tuft Exudative Interstitial Tubular
Patient days % Glum % Glum proliferation necrosis changes inflammation atrophy
Glomerular
immuno-
fluorescence (IgG)
33 39 27 12 — + — + + L,1+,CW
2 IS 94 94 6 — + + + — Negative
41 96 96 2 — — — + — ND
3 18 93 93 7 — + + + + Negative
300 0 0 100 — — — — + ND
4 21 100 100 0 — + + + — ND
5 21 100 100 0 — + + + — L,3+,CW
54 EN EN 0 — + + + L,3+,CW
6 16 100 100 0 — — + + — ND
7 32 100 100 17 — + — + + Negative
75 91 73 9 — + — — + ND
8 51 37 5 5 — + + + — Negative
72 57 34 3 — + + + — Negative
9 157 60 0 88 — — — + + L&G,2+,CW
10 150 78 0 75 + — — + + G,l+,CW&M
Abbreviations are: EN, extensive necrosis; ND, not done; G, granular; L, linear; CW, capillary wall; M, mesangial.
Table 2. Group 11 morphologic features
Crescents
Time from Total Circumferential Global Focal
clinical onset sclerosis endocapillary Tuft Exudative Interstitial Tubular
Patient days % Glum % Glum proliferation necrosis changes inflammation atrophy
Glomerular
immuno-
fluorescence (IgG)
11 24 44 0 33 + — — + + ND
340 48 0 57 — — + + Negative
12 30 76 43 57 + — — + + G,3+,CW
13 450 29 12 88 — — — + + Negative
14 66 17 9 22 + — + + + Negative
15 423 60 0 0 + — — + + G,3+,CW
962 40 0 33 — — + + G&L,3 + ,CW&M
996 80 0 75 — — — — + ND
16 383 29 0 0 — + ND
553 70 50 20 — — — + + ND
17 1000 67 22 33 + + — + + L,3+,CW
18 210 57 0 14 — + + + + L&G.2+,CW&M
19 119 21 0 35 + — + + + L,l+,CW
20 2280 33 22 22 + — — + + G,2+,CW
2454 0 0 100 — — — — + ND
21 2425 II 0 0 — — — — + ND
3399 50 17 50 + — — — + ND
22 180 83 0 80 — — + + Negative
23 1000 55 28 14 + + — + + L&G,2+,CW
24 2343 50 0 25 + — — + ND
2384 28 14 12 — — — — + ND
25 41 44 0 56 + — — + + Negative
26 7 67 17 0 — + + + — ND
158 47 27 47 — — + + G,3+,CW
Abbreviations are: ND, not done; C, granular; L, linear; CW, capillary wall; M, mesangial.
Nos. 22, 23 and 24 have shown deterioration of renal function
during periods ranging up to 6-1/2 years, No. 25 has stable
function at four years, and No. 26 has improved. Eight of the 11
who progressed to uremia were nephrotic, while none of the
five who failed to become uremic developed the nephrotic
syndrome. Among the eight patients in Group 11 who initially
showed fewer than 50% crescents (range 17 to 44%), all but one
ultimately progressed to renal failure.
Pathology
Group I, light microscopy. Eight patients in Group I (Nos.
1—8) underwent biopsy within 60 days of appearance of clinical
manifestations (Fig. 1, Table I). Six of these showed greater
than 90% crescents, essentially all circumferential. Crescents
involved approximately 40% of glomeruli in the two others
(Table 1). Fewer than 20% sclerotic glomeruli were present and
crescents were predominantly cellular. Patients No. 9 and 10
were not biopsied until approximately 22 weeks after onset.
Their specimens showed 60% and 78% crescents and extensive
global sclerosis; crescents were fibrocellular or fibrous. Oliguria
was observed in five of the six patients with greater than 90%
total and circumferential crescents. Percent circumferential
crescents correlated directly with percent total crescents (r =
0.84, P < 0.001). Endocapillary hypercellularity was absent in
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Group I except in patient No. 10; however, tuft necrosis or
exudative changes were present in 8 specimens.
Immunofluorescence and electron microscopy. Results of
immunofluorescence microscopy for IgG are displayed in Table
1. In addition all specimens were positive for fibrin in crescents;
two also showed fibrin in the glomerular tuft. Electron micros-
copy, performed on four biopsies, revealed tuft collapse in
three specimens and basement membrane fragmentation in two.
Electron dense deposits were absent.
Group ii, light microscopy. Reflecting insidious appearance of
clinical manifestations, renal biopsies were generally performed in
Group II patients only after many months of known disease (Table
2). In five patients renal biopsy was performed within two months
of clinical presentation, in three after four to seven months, and in
the remaining eight after one to seven years. Eight initial renal
biopsy specimens showed crescents in 50% or more of glomeruli
(range 50 to 83%); two others showed crescents in 50% or more of
glomeruli on repeat biopsy. Crescents affected an average of 31%
of glomeruli in the six remaining patients; nevertheless, all but one
progressed to renal failure. The percent circumferential crescents
did not exceed 50% in any patient and did not correlate with the
percent total crescents. In initial specimens crescents were pre-
dominantly cellular or fibrocellular. Although late biopsies tended
to be characterized predominantly by fibrocellular and fibrous
crescents, cellular crescents were observed not infrequently in
both early and late specimens. Global sclerosis involved less than
one—third of glomeruli in most initial specimens. Focal endocapil-
lary hypercellularity was present in 10 initial biopsies. Six exhib-
ited tuft necrosis and/or exudative changes in glomeruli.
Sequential analysis showed an increase in globally sclerotic
glomeruli in seven of eight repeat specimens from a mean of
13% to 55% of glomeruli and increased numbers of fibrocellular
crescents. Both increases and decreases in crescent number
were observed. Diffuse interstitial inflammation, prominent in
initial biopsies, regressed and became predominantly focal in
association with tubular atrophy.
Immunofluorescence and electron microscopy. Results of
immunofluorescence microscopy for IgG are displayed in Table
2. In addition, C3 was present in a granular capillary wall
pattern in seven specimens and was absent in four. Fibrin was
found in crescents in six, in glomerular tufts in three, and was
absent in three of the nine specimens evaluated. Electron
microscopy was performed in nine of 16 biopsies. Electron
dense deposits were seen in four (mesangial in 1, subendothelial
in I and in both locations in 2). Basement membrane fragmen-
tation, lucencies and reduplication were present in three spec-
imens and tuft collapse in two.
Discussion
The large number of publications dealing with crescentic
glomerulonephritis stands in contrast to the rarity of this
pathologic entity, which comprises only Ito 2% of renal biopsy
specimens in most series [31. The dramatic evolution to death or
uremia within weeks or months which may be observed with
the rapidly progressive form is the focal point of most reports,
while the spectrum of clinical severity which may be associated
with idiopathic crescentic glomerulonephritis has not been
generally appreciated. Though it is recognized that patients
with circumferential cellular crescents involving greater than
80% of glomeruli usually progress rapidly to renal failure, the
long—term course of patients with less extensive extracapillary
involvement has not been stressed [I].
In the present study we call attention to a group of individuals
with crescentic glomerulonephritis who follow a clinical course
which differs greatly from RPGN. Such patients may have
fewer than 50% crescents early in their disease, generally
demonstrate increased numbers of mixed cellular and fibrous
crescents later, and almost invariably progress to uremia over a
period of months to years. We stress the existence of 'not so
rapidly progressive" crescentic disease in view of the present
widely held view that fails to recognize a spectrum but generally
equates crescentic glomerulonephritis with RPGN. This form of
glomerular disease can be readily identified clinically by the
highly distinctive constellation of hematuria, a tendency to
heavy proteinuria, and an inexorable decline in renal function
over many months to years.
The description of a spectrum of clinical and morphologic
features in patients with extracapillary proliferation is not
meant to imply varying degrees of severity in a single patho-
genic entity. In fact, the variable presence of endocapillary
hypercellularity and necrosis in glomeruli and the heterogeneity
of immunofluorescence findings suggest the contrary. How-
ever, since certain clinical and morphologic correlations are
shared by glomerular diseases in which crescent formation
predominates, it is useful to consider these cases as a group. In
fact, it could be argued that systemic disorders in which
crescentic glomerular disease may occur, such as the necrotiz-
ing vasculitides and systemic lupus erythematosis, should also
be included in such a study. We have elected, as others before
us, to restrict ourselves to the idiopathic forms.
In the series of Whitworth et al [1] over one—half of 60 patients
with crescentic glomerulonephritis failed to follow a rapidly pro-
gressive course. Antecedent proteinuna of months to years dura-
tion was documented in almost one—third prior to diagnosis. In
these, progression to uremia was generally indolent although
occasionally punctuated ultimately by an abrupt decline in renal
function. A correlation between percent of glomeruli involved by
crescents and rapidity of progression was not confirmed in their
series, in which biopsy material (as in the present study) was often
obtained long after first appearance of clinical manifestations. It
should be emphasized that the prognostic significance of percent
crescents described by ourselves and others in regard to rate of
progression is based on the extent of circumferential cellular
structures found early. Presumably, abrupt loss of renal function
is attributable to simultaneous involvement of practically all
glomeruli by enveloping crescents. Since a circumferential cres-
cent is probably the prelude to eventual glomerular sclerosis,
remission or response to therapy is greatly dependent on the
numbers of glomeruli so affected. A crescent count made after
survival for many months or years, which is based on cellular and
fibrous structures as well as obsolescent glomeruli (often the case
in the "not so rapidly progressive" form), represents a summation
of crescents of various ages which may have developed in suc-
cesssive waves.
It is not clear whether progression to renal failure in Group II
patients represents the slow evolution of an initial limited
crescentic process or repeated waves of crescent formation [I,
11]. Our demonstration that patients with less than 50% cres-
cents on initial biopsy (in some instances even fewer than 30%)
nonetheless progress to renal failure documents that even
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modest extracapillary disease represents a morbid process
which generally evolves to renal failure. The report by others
that such a protracted course may on occasion be punctuated
by abrupt deterioration in renal function may be related to a
recrudescence of crescent formation [1]. The not infrequent
finding of crescents which are cellular late in the course of
Group II patients and increases in numbers of crescents in serial
biopsies support this hypothesis. In the present study two
patients showed both an increase in the number of crescents
and a greater proportion of cellular crescents one—half and
nearly three years after initial biopsy, suggesting successive
waves of crescent formation. Additionally, hypertension and
hemodynamic adaptations consequent to nephron loss may
contribute to progressive functional deterioration [20].
A broad age distribution, no sex predilection and near uni-
versal hematuria characterized both Groups I and II. The
nephrotic syndrome was rarely observed in Group 1, while it
occurred frequently in Group II, correlating with progressive
glomerular disease and uremia. Hypertension, while an uncom-
mon finding in Group I patients, was almost universal in Group
II. Oligo-anuria, which never occurred in Group II, frequently
accompanied the rapid course to uremia in Group I. The
presence of oliguria correlated with extensive cellular crescent
formation, predominantly circumferential.
Most of our patients in Group I demonstrated greater than
80% involvement of glomeruli with crescents in early biopsies,
nearly all cellular and circumferential. The histologic findings in
Group II, who progressed less rapidly to renal failure, differed
significantly. One—half showed fewer than 50% crescents on
initial biopsy, the percentage of circumferential crescents never
exceeded 50% and a wide spectrum of crescent morphology
from cellular to fibrous co-existed. Specimens in which greater
than 50% ofglomeruli were affected by crescents were gener-
ally obtained many months after the first appearance of clinical
manifestations, when crescents were found to vary greatly in
age. As might be anticipated, sequential analysis of renal tissue
in Group I! often showed an increase in the percentage of
globally sclerotic glomeruli and a conversion to fibrocellular
and fibrous crescents.
In describing the natural history of crescentic glomerulone-
phritis, we have necessarily excluded from consideration pa-
tients with the rapidly progressive form who remitted during
therapy with corticosteroids, cytotoxics and anticoagulants. In
so doing, we may have omitted from Group! a subset of patents
who remit spontaneously or who are more likely to respond to
therapy. In any case, the therapeutic guidelines in typical
RPGN (our Group I), have been clearly expounded by others
[3, 17—19]. Aggressive therapy with pulse methylprednisolone,
cytotoxics or plasmapheresis can be expected to induce remis-
sion in some. What are the implications of the present study in
regard to therapy of "not so rapidly progressive" crescentic
glomerulonephritis? Since patients with this rather indolent
course do, nevertheless, progress ultimately to uremia, aggres-
sive therapy would appear to be equally justified here as long as
cellular crescents are present and advanced glomerular sclero-
sis has not yet supervened. Repeated courses may be mandated
according to our concept that this form probably progresses in
some instances as a result of recurrent waves of activity.
Clearly, any judgment as to the efficacy of therapy will be
limited by the more protracted course of the "not so rapidly
progressive" form. Failure of crescentic glomerulonephritis to
follow a malignant course cannot be necessarily credited to
therapy in the light of the findings reported herein.
Reprint requests to David S. Baldwin, M.D., Renal and Hypertension
Division, Department of Medicine, New York University Medical
Center. 550 First Avenue, New York, N.Y. 10016, USA.
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